Metito is implementing a desalination plant in Al-Arish area with a capacity of 100,000 cubic metres per day in the first phase at a cost of EGP 1.6bn.

“The project is implemented in cooperation with Orascom, and the desalinated water from this plant is sufficient for 750,000 people,” said Kareem Madour, chief executive of Metito.

The project will be completed in 2021 and is part of the overall development plan in Sinai.

He told Daily News Egypt, during a roundtable held by the company yesterday, that the company is interested in building sea water desalination plants and selling water to the Holding Company for Water & Wastewater. He also said that, if there is an opportunity and vision for the implementation of projects in this system, Metito will be among the first companies to apply, considering it has implemented a number of projects in different countries, including Rwanda and China.

He explained that the volume of the company’s work in all countries is worth $2bn. In Egypt, the company has business worth $200m. The company is now working in 40 desalination and treatment plants.

The desalination plant in Hurghada was delivered. It will output 80,000 cubic metres of water per day, serving 50,000 people at a cost of EGP 800m. The company manages the project after its implementation for a period of one to five years.

The company has also implemented the first phase of a desalination plant in Jabal Al-Jalalah area with a total capacity of 150,000 cubic metres per day. The station is executed on an area of 60,000 sqm and will serve about a million people.

2019 Daily News Egypt. Provided by SyndiGate Media Inc. (

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an as is and as available basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.